Your widget preview
RSS feeds
Be the first to announce the news!!
|
Argos Therapeutics Presents Positive Phase 2 Viral Load And Immune... Main Category: HIV / AIDS Also Included In: Immune System / Vaccines Article Date: 23 Oct 2009 Argos Therapeutics announced two presentations at the AIDS Vaccine 2009 conference, detailing positive viral load, immune response and safety data from an ongoing Phase 2a trial of AGS-004, its personalized immunotherapy candidate. Topix.netHalozyme Announces Roche Doses First Patient In Phase 3 Clinical Trial With Subcutaneous Herceptin Halozyme Therapeutics, Inc. and Roche announced dosing of the first patient in a Phase 3 registration trial using Enhanze technology in a subcutaneous formulation with Roche's anticancer biologic, Herceptin . Topix.netU.S. Attorneys `back off` prosecuting medicinal marijuana users The federal government announced this week that it will no longer seek to prosecute patients using medicinal marijuana if the practice of prescribing it is legal within that patient's state. Join TogetherRCN Announces Winners Of 2009 Mary Seacole Award, UK Five healthcare professionals were presented with Mary Seacole Leadership and Development Awards at a ceremony held at the Royal College of Nursing (RCN) headquarters in London. The awards will specifically help meet health needs of people from Black and minority ethnic communities. The winners were announced at the ceremony. Professor Ann Keen MP, Parliamentary Under Secretary of State for Health, who also delivered a keynote speech to delegates at the ceremony. Medical News TodayAerie Pharmaceuticals` ROCK Inhibitor, AR-12286, Demonstrates Positive Results In Glaucoma Patients In A Phase 2a Study Aerie Pharmaceuticals, a biotechnology company focused on the discovery and development of novel treatments for glaucoma, announced positive results from a Phase 2a study of its Rho-kinase (ROCK) inhibitor, AR-12286. The study evaluated the safety, tolerability and efficacy of three different doses of AR-12286 in 88 patients with primary open angle glaucoma or ocular hypertension. according to the study results, AR-12286 was safe and well-tolerated. Medical News TodayNew Animal Study Featured In The Journal Of Cellular Biochemistry Supports Rexahn`s ArchexinT As Potent Inhibitor Of Human Cancer Cell Growth Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and central nervous system (CNS) therapeutics, announced the results of an animal study that further demonstrates the company's Phase II oncology drug, ArchexinT, as having the potential to target and treat multiple life-threatening cancers. Medical News Today |
Updating news archive  |
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Popular search keywords in health:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Available news archives.
How does Feedzilla work?
Feedzilla is a news aggregator which categorizes news stories by topic. It is a platform where webmasters and bloggers can find an unmatched selection of easy to use, automatically updating and professional news widgets for their sites. Feedzilla supports the building of widgets in various formats, as well as allowing the addition of news widgets to different blogging platforms and social networks.
Feedzilla manually aggregates news summaries found in RSS feeds, and redistributes them in either RSS format or as a news widget. Content is collected 24 hours a day, 7 days a week from an ever-growing list of providers.
Hot keywords
accused plot • accused seeking • acting attorney • administration plans • alive scottish • already fretting • american shopping • attack mall • attack malls • big pay • black barbies • board building • building downtown • bulatci attempted • charged providing • chinas gdp • companies already • companies received • compensation board • compensation highest • de janeiro • death rcmp • downtown edmonton • draft deal • edmonton surrendered • ends surrender • england man • failed terrorist • firms obama • found body • fretting holiday • friends tried • gunman held • halloween offers • held hostages • heroin trade • hn vaccine • holiday shopping • hostages edmonton • hostages workers • iran nuclear • kill kidnap • kill politicians • kill prominent • lockerbie bomber • maim injure • mall attack • malls authorities • man charged • manslaughter shooting • mass man • massachusetts man • material support • missile defense • mountie murder • muslim school • north korea • nuclear watchdog • nuclear weapons • obama administration • offers hope • officer hay • olympics rio • order companies • overseas kill • paid executives • pay cuts • percent quarter • planning trips • plea rejected • plead guilty • plot attack • police looking • politicians randomly • president joe • purple lady • recession companies • rife favoritism • river nwt • season halloween • seeking training • shoot people • shopping mall • shopping season • surrender gunman • swine flu • tarek mehanna • terror plot • terror suspect • then plotted • too westernized • training camps • training taliban • trial emrah • workers compensation •
News poll
Press release
9th of September 2009 - Interview of Feedzilla's founder at the IFA in Berlin. [More]
Testimonials
Guys, your services are great and so easy to use. Well done!
John Lecter
© 2009 Butterfly Effect SA